drug study acis
Post on 08-Apr-2018
219 Views
Preview:
TRANSCRIPT
-
8/7/2019 drug study acis
1/3
GENERIC
NAME
DOSAGE/
FREQUENCY
CLASSIFICATION INDICATIONS CONTRAINDICATION
S
SIDE EFFECT(S) NSG.
RESPONSIBILITIES
Carvedilol 3.125 mg BID for 2weeks may be
increased to 6.25
mg BID. Double
dose every 2 weeks
to the highest
tolerated by the
patient.
Beta-blocker treatment of mildto
moderate congest
ive heart
failure (CHF).
2nd
or 3rd
degreeheart block, severely
bradychardia, shock,
uncontrolled heart
failure, asthma.
The most commonside effects are
dizziness, fatigue,
hypotension,
diarrhea, asthenia,
bradychardia, and
weight gain.
Monitor for use ofother similar
acting drugs eg:
alcohol.
Monitor vital
signs, assess for
risk factors.
Instruct client not
to take a doubledose if they miss a
dose.
Warn not to stop
the medication
suddenly due to
the rsik of
rebound
hypertension.Ramipril HTN: initial dose
1.25 mg OD. CHF:
initially 1.25 mg
OD. MI: 2.5 mg BID.
Maintenance dose:
10 mg OD.
ACE inhibitor Treatment of CHF,
HTN/HPN, MI.
Aortic stenosis or
outflow tract
obstruction,
pregnancy.
may cause swelling
of the mouth,
tongue, or throat
low blood sugar in
patients taking
other medicine for
diabetes which
shows as sweatingor shakiness
Dry cough may
develop, dizziness,
and light-
headedness due to
low blood pressure.
(It is recommended
Monitor for use of
other similar
acting drugs eg:
alcohol.
Monitor vital
signs, assess for
risk factors.
Instruct client notto take a double
dose if they miss a
dose.
Warn not to stop
the medication
suddenly due to
the rsik of
-
8/7/2019 drug study acis
2/3
to start treatment
with the lowest
dose.)decreased sex drive
tiredness and
fatigue especially in
the early stages
mouth dryness in
the early stages
rebound
hypertension.
Clopidogrel 1 tablet OD Anticoagulant,
antiplatelet,fibronolytic
(thrombolytic)
used to inhibit
blood clotsincoronary artery
disease, periphera
l vascular disease,
and cerebrovascul
ar disease.
Active pathological
bleeding
Severe neutropenia
(low white bloodcells)
Thrombotic
thrombocytopenic
purpura (TTP)
Hemorrhage - The
annual incidence of
hemorrhage may
be increased by theco-administration
of aspirin.
Monitor for
bleeding.Monitor
coagulation ratios
(INR's).
Implement
appropriate safety
measures to
prevent bleeding
ISMN
(Isosorbide
Mononitrate
)
1 cap/tab OD Anti-anginal Treatment for
angina pectoris
Hypersensitivity to
nitrate compounds.
Uncompensated
cardiac failure,
cardigenic shock,
marked bradycardia.
Headache
necessitating
withdrawal
Tiredness, sleep
disturbances and
gastrointestinaldisturbances
Asses location,
duration, intensity
of anginal pain.
Assess vital signs
regularily.
Monitor forhypotension
Simvastatin Initially 10 mg once
daily. Max: 40 mg
once daily
Dyslipidaemic
agent
Treatment of
hypercholesterole
mias
Abdominal pain,
diarrhea, indigestion,
and a general feeling
of weakness.
Active liver disease
or unexplained
persistent
elevations of serum
transaminases.
Pregnancy and
Assess nutrition:
fat, protein,
carbohydrates
Monitor bowel
pattern daily
Monitor
-
8/7/2019 drug study acis
3/3
lactation. triglycerides,
cholesterol
baselinethroughout
treatment
top related